Amelioration of collagen-induced arthritis in rats by Nanogold

Arthritis and Rheumatism

Volumn 56, Issue 2, 2007, Pages 544-554

  Tsai, Chiau Yuang ^a   Shiau, Ai Li ^a   Chen, Shih Yao ^a   Chen, Yu Hung ^a   Cheng, Pai Chiao ^a   Chang, Meng Ya ^a   Chen, Dong Hwang ^a   Chou, Chen Hsi ^a   Wang, Chrong Reen ^b   Wu, Chao Liang ^b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GOLD; INTERLEUKIN 1BETA; NANOGOLD; NANOPARTICLE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; ARTICLE; CARTILAGE DEGENERATION; CELL INFILTRATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; ENDOTHELIUM CELL; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASIA; LEUKOCYTE; MACROPHAGE; MALE; MICROVASCULATURE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SYNOVIAL FLUID;

ANIMALS; ARTHRITIS, RHEUMATOID; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; CYTOKINES; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; GOLD; HUMANS; INFLAMMATION; INJECTIONS, INTRA-ARTICULAR; MACROPHAGES; MALE; METAL NANOPARTICLES; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; SYNOVIAL MEMBRANE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33847069149     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22401     Document Type: Article

References (45)

1. FitzGerald O, Soden M, Yanni G, Robinson R, Bresnihan B. Morphometric analysis of blood vessels in synovial membranes obtained from clinically affected and unaffected knee joints of patients with rheumatoid arthritis. Ann Rheum Dis 1991;50:792-6.
2. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
3. Koch AE. Angiogenesis as a target in rheumatoid arthritis. Ann Rheum Dis 2003;62 Suppl 2:860-7.
4. Paleolog EM. Angiogenesis in rheumatoid arthritis. Arthritis Res 2002;4 Suppl 3:S81-90.
5. Szekanecz Z, Gaspar L, Koch AE. Angiogenesis in rheumatoid arthritis. Front Biosci 2005;10:1739-53.
6. Fava RA, Olsen NJ, Spencer-Green G, Yeo KT, Yeo TK, Berse B, et al. Vascular permeability factor/endothelial growth factor: accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 1994;180:341-6.
7. Lu J, Kasama T, Kobayashi K, Yoda Y, Shiozawa F, Hanyuda M, et al. Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis. J Immunol 2000;164:5922-7.
8. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, et al. Vascular endothelial growth factor: a cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994;152:4149-56.
9. Tischer E, Mitchell R, Hartman T, Suva M, Gospodarowicz D, Fiddes JC, et al. The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991;266:11947-54.
10. Keyt BA, Berleau LT, Nguyen HV, Chen H, Heinsohn H, Vandlen R, et al. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem 1996;271:7788-95.
11. Lee SS, Joo YS, Kim WU, Min DJ, Min JK, Park SH, et al. Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol 2001;19:321-4.
12. Jou IM, Shiau AL, Chen SY, Wang CR, Shieh DB, Tsai CS, et al. Thrombospondin 1 as an effective gene therapeutic strategy in collagen-induced arthritis. Arthritis Rheum 2005;52:339-44.
13. Wang CR, Chen SY, Wu CL, Liu MF, Jin YT, Chao L, et al. Prophylactic adenovirus-mediated human kallistatin gene therapy suppresses rat arthritis by inhibiting angiogenesis and inflammation. Arthritis Rheum 2005;52:1319-24.
14. Yoo SA, Bae DG, Ryoo JW, Kim HR, Park GS, Cho CS, et al. Arginine-rich anti-vascular endothelial growth factor (anti-VEGF) hexapeptide inhibits collagen-induced arthritis and VEGF-stimulated productions of TNF-α and 1L-6 by human monocytes. J Immunol 2005;174:5846-55.
15. Sokolov K, Follen M, Aaron J, Pavlova I, Malpica A, Lotan R, et al. Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer Res 2003;63:1999-2004.
16. Mirkin CA, Letsinger RL, Mucic RC, Storhoff JJ. A DNA-based method for rationally assembling nanopartides into macroscopic materials. Nature 1996;382:607-9.
17. Alivisatos AP, Johnsson KP, Peng X, Wilson TE, Loweth CJ, Bruchez MP Jr, et al. Organization of "nanocrystal molecules" using DNA. Nature 1996;382:609-11.
18. Tsai CY, Shiau AL, Cheng PC, Shieh DB, Chen DH, Chou CH, et al. A biological strategy for fabrication of Au/EGFP nanoparticle conjugates retaining bioactivity. Nano Lett 2004;4:1209-12.
19. Levy R, Thanh NT, Doty RC, Hussain I, Nichols RJ, Schiffrin DJ, et al. Rational and combinatorial design of peptide capping ligands for gold nanoparticles. J Am Chem Soc 2004;126:10076-84.
20. Selvakannan PR, Mandal S, Phadtare S, Pasricha R, Sastry M. Capping of gold nanopartides by the amino acid lysine renders them water-dispersible. Langmuir 2003;19:3545-9.
21. Porter LA, Ji D, Westcott SL, Graupe M, Czernuszewicz RS, Halas NJ, et al. Gold and silver nanoparticles functionalized by the adsorption of dialkyl disulfides. Langmuir 1998;14:7378-86.
22. Mukherjee P, Bhattacharya R, Wang P, Wang L, Basu S, Nagy JA, et al. Antiangiogenic properties of gold nanoparticles. Clin Cancer Res 2005;11:3530-4.
23. Bhattacharya R, Mukherjee P, Xiong Z, Atala A, Soker S, Mukhopadhyay D. Gold nanopartides inhibit VEGF165-induced proliferation of HUVEC cells. Nano Lett 2004;4:2479-81.
24. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
25. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al, for the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986;29:1039-49.
26. Grabar KC, Freeman RG, Hommer MB, Natan MJ. Preparation and characterization of Au colloid monolayers. Anal Chem 1995; 67:735-43.
27. Park CC, Morel JC, Amin MA, Connors MA, Harlow LA, Koch AE. Evidence of IL-18 as a novel angiogenic mediator. J Immunol 2001;167:1644-53.
28. Zhang M, Desai T, Ferrari M. Proteins and cells on PEG immobilized silicon surfaces. Biomaterials 1998;19:953-60.
29. Vertegel AA, Siegel RW, Dordick JS. Silica nanoparticle size influences the structure and enzymatic activity of adsorbed lysozyme. Langmuir 2004;20:6800-7.
30. Lundqvist M, Sethson I, Jonsson BH. Protein adsorption onto silica nanoparticles: conformational changes depend on the particles' curvature and the protein stability. Langmuir 2004;20:10639-47.
31. Ikeda M, Hosoda Y, Hirose S, Okada Y, Ikeda E. Expression of vascular endothelial growth factor isoforms and their receptors Flt-1, KDR, and neuropilin-1 in synovial tissues of rheumatoid arthritis. J Pathol 2000;191:426-33.
32. Pufe T, Petersen W, Tillmann B, Mentlein R. Splice variants VEGF121 and VEGF165 of the angiogenic peptide vascular endothelial cell growth factor are expressed in the synovial tissue of patients with rheumatoid arthritis. J Rheumatol 2001;28:1482-5.
33. Shukla R, Bansal V, Chaudhary M, Basu A, Bhonde RR, Sastry M. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 2005;21:10644-54.
34. Karlsson M, Martensson LG, Jonsson BH, Carlsson U. Adsorption of human carbonic anhydrase II variants to silica nanoparticles occur stepwise: binding is followed by successive conformational changes to a molten-globule-like state. Langmuir 2000;16:8470-9.
35. Jiang X, Jiang J, Jin Y, Wang E, Dong S. Effect of colloidal gold size on the conformational changes of adsorbed cytochrome c: probing by circular dichroism, UV-visible, and infrared spectroscopy. Biomacromolecules 2005;6:46-53.
36. Yamashita A, Yonemitsu Y, Okano S, Nakagawa K, Nakashima Y, Irisa T, et al. Fibroblast growth factor-2 determines severity of joint disease in adjuvant-induced arthritis in rats. J Immunol 2002;168:450-7.
37. Nagashima M, Wauke K, Hirano D, Ishigami S, Aono H, Takai M, et al. Effects of combinations of anti-rheumatic drugs on the production of vascular endothelial growth factor and basic fibroblast growth factor in cultured synoviocytes and patients with rheumatoid arthritis. Rheumatology (Oxford) 2000;39:1255-62.
38. Merchant B. Gold, the noble metal and the paradoxes of its toxicology. Biologicals 1998;26:49-59.
39. Berse B, Hunt JA, Diegel RJ, Morganelli P, Yeo K, Brown F, et al. Hypoxia augments cytokine (transforming growth factor-β and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin Exp Immunol 1999;115:176-82.
40. Jackson JR, Minton JA, Ho ML, Wei N, Winkler JD. Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1β. J Rheumatol 1997;24:1253-9.
41. Bottomley MJ, Webb NJ, Watson CJ, Holt PJ, Freemont AJ, Brenchley PE. Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor: specific up-regulation by tumour necrosis factor-α in synovial fluid. Clin Exp Immunol 1999;117:171-6.
42. Saxne T, Palladino MA Jr, Heinegard D, Talal N, Wollheim FA. Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988;31:1041-5.
43. Hopkins SJ, Humphreys M, Jayson MI. Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1. Clin Exp Immunol 1988;72:422-7.
44. Mor F, Quintana FJ, Cohen IR. Angiogenesis-inflammation cross-talk: vascular endotheiiai growth factor is secreted by activated T cells and induces Th1 polarization. J Immunol 2004;172:4618-23.
45. Hainfeld JF, Slatkin DN, Smilowitz HM. The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol 2004; 49:N309-15.